"The Company is also evaluating other funding options for the Vidalia Further Expansion project including commercial bank funding, equity partnership and joint venturing".
It would be interesting to see what will happen in this space and the option they will take.
- Forums
- ASX - By Stock
- SYR
- Ann: March 2024 Quarterly Activities Presentation
SYR
syrah resources limited
Add to My Watchlist
1.96%
!
26.0¢

Ann: March 2024 Quarterly Activities Presentation, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
26.0¢ |
Change
0.005(1.96%) |
Mkt cap ! $270.9M |
Open | High | Low | Value | Volume |
25.5¢ | 27.3¢ | 25.5¢ | $634.3K | 2.391M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 379430 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 40672 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 379430 | 0.260 |
9 | 238069 | 0.255 |
16 | 483863 | 0.250 |
13 | 503263 | 0.245 |
22 | 860417 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 40672 | 5 |
0.270 | 144245 | 2 |
0.275 | 628178 | 11 |
0.280 | 177739 | 6 |
0.285 | 418600 | 6 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SYR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online